Empracet | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Empracet
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

xyz-pharma-m-2025-01-27

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

Empracet

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

118 API Suppliers, 80 USDMF, 21 CEP/COS, 16 JDMF, 7 EU WC, 108 KDMF, 106 NDC API, 33 Listed Suppliers, $ API Reference Price

118 API Suppliers
80 USDMF
21 CEP/COS
16 JDMF
7 EU WC
108 KDMF
106 NDC API
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

42 Drugs in Development

42 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2598 FDF Dossiers, 730 FDA Orange Book, 503 Europe, 291 Canada, 75 Australia, 375 South Africa, 624 Listed Dossiers

2598 FDF Dossiers
730 FDA Orange Book
503 Europe
291 Canada
75 Australia
375 South Africa
624 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

SUPPOSITORY;RECTAL - 120MG
SUPPOSITORY;RECTAL - 325MG
SUPPOSITORY;RECTAL - 650MG
SUPPOSITORY;RECTAL - 80MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 325MG;37.5MG
SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG;15MG
TABLET;ORAL - 300MG;30MG
TABLET;ORAL - 300MG;60MG
TABLET;ORAL - 325MG;5MG
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 1 Evonik, 14 Rochem International Inc, 31 SPI Pharma, 2 Seqens, 32 DKSH, 3 Pharm-RX Chemical, 11 Faran Shimi Pharmaceutical, 14 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 11 Gangwal Healthcare, 21 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 1 Pramukh Pharmachem, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 4 Finar, 17 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 13 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

139 Fillers, Diluents & Binders, 79 Thickeners and Stabilizers, 71 Solubilizers, 69 Coating Systems & Additives, 59 Taste Masking, 54 Topical, 50 Direct Compression, 46 Disintegrants & Superdisintegrants, 45 Parenteral, 40 Film Formers & Plasticizers, 40 Granulation, 39 Lubricants & Glidants, 38 Controlled & Modified Release, 27 Chewable & Orodispersible Aids, 26 Emulsifying Agents, 19 Co-Processed Excipients, 18 Rheology Modifiers, 15 Surfactant & Foaming Agents, 14 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

139 Fillers, Diluents & Binders
79 Thickeners and Stabilizers
71 Solubilizers
69 Coating Systems & Additives
59 Taste Masking
54 Topical
50 Direct Compression
46 Disintegrants & Superdisintegrants
45 Parenteral
40 Film Formers & Plasticizers
40 Granulation
39 Lubricants & Glidants
38 Controlled & Modified Release
27 Chewable & Orodispersible Aids
26 Emulsifying Agents
19 Co-Processed Excipients
18 Rheology Modifiers
15 Surfactant & Foaming Agents
14 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 348 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
348 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 406 Finished Drug Prices, 20 Annual Reports

7 US Medicaid Prescriptions
406 Finished Drug Prices
20 Annual Reports

MARKET PLACE

179 APIs, 95 FDF Dossiers

179 APIs
95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 2 US Exclusivities, 3 Health Canada Patents

41 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 7 USP, 1 JP, 26 Others

1 EDQM
7 USP
1 JP
26 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

2 BioAnalytical Methods
8 Analytical Methods

$ API Ref.Price (USD/KG) : 7 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Mallinckrodt Canada

02 2Mallinckrodt Pharmaceuticals Inc

filter Patent Reset all filters

3 All

01 12233924

02 12415403

03 12705733

filter Product Reset all filters

3 All

01 3Acetaminophen

filter Dosage Reset all filters

3 All

01 3Solution

filter Exp Date Reset all filters

3 All

01 12017-08-05

02 12021-06-06

03 12028-11-13

Granules Paracetamol

Product Main Page

01

Mallinckrodt Pharmaceuticals Inc

Paracetamol

33rd NZW-Hamburg

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

33rd NZW-Hamburg

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2415403

Filing Date : 2001-06-06

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2021-06-06

Date Granted : 2011-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Mallinckrodt Canada

Paracetamol

33rd NZW-Hamburg

Not Confirmed

Mallinckrodt Canada

33rd NZW-Hamburg

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2233924

Filing Date : 1997-08-05

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2017-08-05

Date Granted : 2012-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Mallinckrodt Pharmaceuticals Inc

Paracetamol

33rd NZW-Hamburg

Not Confirmed

Mallinckrodt Pharmaceuticals Inc

33rd NZW-Hamburg

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Paracetamol

Brand Name : OFIRMEV?

Patent Number : 2705733

Filing Date : 2008-11-13

Strength per Unit : 10 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2028-11-13

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?